1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Russia Pharmaceuticals and Healthcare Report Q1 2017

Russia Pharmaceuticals and Healthcare Report Q1 2017

  • November 2016
  • -
  • Business Monitor International
  • -
  • 91 pages

Includes 3 FREE quarterly updates


BMI View:

Russia’s healthcare market is in a precarious position due to a severe lack of funding and an escalating burden of disease. Amendments to Russia’s pharmaceutical legislation will favour domesticallyproduced medicines over foreign drugmakers and multinational drugmakers will be pressured to establish a domestic manufacturing presence to comply with related new regulations. Nonetheless, given its sheer market size and unmet potential, the country will remain attractive for investment by multinational pharmaceutical firms for long-term growth.

Headline Expenditure Projections



- Pharmaceuticals: RUB1.01trn (USD16.6bn) in 2015 to RUB1.01trn (USD16.5bn) in 2016; +9.0% in local currency terms and -0.3% in US dollar terms. Forecast revised downwards from last quarter.

- Healthcare: RUB5.28trn (USD86.2bn) in 2015 to RUB5.57trn (USD83.1bn) in 2016; +5.4% in local currency terms and -3.6% in US dollar terms. Forecast unchanged from last quarter.

Table Of Contents

Russia Pharmaceuticals and Healthcare Report Q1 2017
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Russia 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Russia 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Russia 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Russia 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Russia 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Russia 2012-2020) 20
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Russia 2012-2020) 22
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Russia 2012-2020) 24
OTC Medicine Market Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Russia 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Russia 2014-2020) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Russia 2014-2020) 29
Industry Risk/Reward Index 30
Central And Eastern Europe Risk/Reward Index 30
Russia Risk/Reward Index 37
Rewards 37
Risks 38
Regulatory Review 39
Intellectual Property Issues 41
Pricing Regime 43
Reimbursement Regime 47
Market Overview 49
Healthcare Sector 50
Table: Healthcare Resources (Russia 2010-2015) 51
Table: Healthcare Personnel (Russia 2010-2015) 51
Table: Healthcare Activity (Russia 2010-2015) 52
Research and Development 52
Clinical Trials 53
Competitive Landscape 58
Research-Based Industry 59
Table: Recent Developments 60
Table: Multinational Market Activity 61
Generic Drugmakers 62
Table: Activity Of Russian Drugmakers Independent Of Multinational Investment 63
Pharmaceutical Retail Sector 64
Company Profile 67
Johnson and Johnson 67
Novartis 70
Pharmstandard 74
Veropharm 78
Demographic Forecast 80
Demographic Outlook 80
Table: Population Headline Indicators (Russia 1990-2025) 81
Table: Key Population Ratios (Russia 1990-2025) 81
Table: Urban/Rural Population and Life Expectancy (Russia 1990-2025) 82
Table: Population By Age Group (Russia 1990-2025) 82
Table: Population By Age Group % (Russia 1990-2025) 83
Glossary 85
Methodology 87
Pharmaceutical Expenditure Forecast Model 87
Healthcare Expenditure Forecast Model 87
Notes On Methodology 88
Risk/Reward Index Methodology 89
Index Overview 90
Table: Pharmaceutical Risk/Reward Index Indicators 90
Indicator Weightings 91

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.